The ability of granulocyte-macrophage colony-stimulating factor (GM-CSF) and G-CSF to influence hematopoiesis in long-term cultures (LTC) of human marrow was studied by cocultivating light density normal human marrow cells with human marrow fibroblast feeders engineered by retroviral infection to constitutively produce one of these growth factors. Feeders producing stable levels of 4 ng/mL GM-CSF or 20 ng/mL G-CSF doubled the output of mature nonadherent cells. The numbers of both colony forming unit-GM (CFU-GM) and erythroid burst forming unit (BFU-E) in the G-CSF LTC were also increased (twofold and fourfold, respectively, after 5 weeks in culture), but this effect was not seen with the GM-CSF feeders. At the time of the weekly half medium change 'H-thymidine suicide assays showed primitive adherent layer progenitors in LTC to be quiescent in both the control and GM-CSF cultures. In contrast, in the G-CSF cultures, a high proportion of primitive progenitors were in S-phase. A single addition of either recombinant GM-CSF or G-CSF to LTC in doses as high as 80 ng/mL and 150 ng/mL,
HE GROWTH O F normal hematopoietic cells in
T colony assays in vitro requires the addition of specific glycoprotein regulators commonly referred to as hematopoietic growth factors.' Two of these are granulocytemacrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF). The cloning of the genes for these molecules and the availability of recombinant proteins has allowed confirmation of the activity of these materials as stimulators of the growth and differentiation of both granulocytes and macrophages.'.' In addition, the ability of these two factors to directly stimulate erythroid and multilineage progenitors, and synergy both with each other and with other factors such as interleukin-3 (IL-3) and IL-6 has been Both GM-CSF and G-CSF cause granulocytosis when administered in pharmacologic doses in primates and humans? and GM-CSF may also stimulate production of monocytes and platelets. However, the role of these molecules in regulating normal hematopoiesis in vivo within the marrow microenvironment is unknown.
Long-term marrow cultures (LTC) have been found to mimic many of the features of marrow hematopoiesis."*" In this system a complex mesenchymal cellular environment forms that is essential for the sustained output of hematopoietic cells.lO~l' Primitive hematopoietic cells are selectively retained in this adherent layer and proliferate and differentiate releasing their mature progeny into the culture medi~m.""~ A regulatory role for the adherent stromal cell population has been demonstrated by the fact that the most primitive clonogenic progenitors in the adherent layer of unstimulated, normal LTC are quiescent, as are such cells in the bone marrow, whereas progenitors of the same type but in suspension and thus lacking contact with the stroma proliferate continu~usly.~~ The addition of mesenchymal cell activators such as IL-lP and platelet-derived growth factor to LTC triggers the adherent layer progenitors into respectively, failed to induce primitive progenitor cycling. However, three sequential daily additions of 150 ng/mL G-CSF did stimulate primitive progenitors to enter S-phase and a single addition of 5 or 12.5 ng/mL of G-CSF together with 10 ng/mL GM-CSF was able to elicit the same effect. Thus, selective elevation of G-CSF in human LTC stimulates proliferation of primitive clonogenic progenitors, which may then proceed through to the terminal stages of granulopoiesis. In contrast, the effects of GM-CSF in this system appear limited to terminally differentiating granulopoietic cells. However, when both GM-CSF and G-CSF are provided together, otherwise biologically inactive doses show strong stimulatory activity. These findings suggest that the production of both of these growth factors by normal stromal cells may contribute to the support and proliferation of hematopoietic cells, not only in LTC, but also in the microenvironment of the marrow in vivo. 0 1991 by The American Society of Hematology.
S-phase." Concomitant with this response is the stimulation of production of a variety of hematopoietic growth factors, including IL-1, IL-6, G-CSF, and GM-CSF, as seen in mRNA from LTC adherent layers and by detection of bioactivity in the culture medium.I6 Based in part on these observations, we have proposed a model of hematopoietic cell regulation in the LTC system in which the pulsed activation of one or all of these factors plays an important role in allowing new cohorts of primitive cells to be sequentially recruited from a quiescent pool to result in sustained granulopoiesis for many weeks.ls~"
According to such a model, one might then anticipate that modifications to the LTC system allowing elevated growth factor levels to be achieved might lead to enhancement of the hematopoietic activity of the primitive cells initially added. To test this hypothesis with respect to GM-CSF and G-CSF, we have analyzed the effects of providing marrow cells in LTC with fibroblasts from normal Leftover human marrow cells were obtained from consenting adults undergoing diagnostic marrow aspiration or marrow harvest before transplantation after approval of the Clinical Screening Committee for Research Involving Human subjects of the University of British Columbia. Light density (< 1.068 g/mL) marrow cells were isolated by passage over a discontinuous Percoll density gradient (Pharmacia Canada, Baie d'Orfe, Quebec, Canada). Adherent layers of primary human marrow fibroblasts were established from unprocessed human marrow as previously described.2y Briefly, cultures were established as for standard LTCs but were maintained at 37°C with weekly complete medium changes until the adherent layer had reached confluence (approximately 2 weeks). To generate hG-or GM-CSF-producing marrow feeders, tissue culture dishes containing these confluent, unpassaged marrow adherent layers were trypsinized and the cells replated at 2 x los cells/60-mm tissue culture dish in a medium with 20% FCS (420% FCS). After overnight incubation at 37°C the growth medium was removed and replaced with 2 mL of medium conditioned by high titer viral producer cells and containing 8 p,g/mL polybrene. After 4 hours of incubation at 3 7 T , the virus-containing medium was replaced with 420% FCS. Two days later the infected cells were retrypsinized and the cells from each dish split into three dishes in 420% FCS containing 0.2 mdmL active concentration G418 (GIBCODRL, Burlington, Ontario, Canada). When the cells had expanded in G41S-containing medium to produce a confluent layer of fibroblasts, their growth medium was tested for growth factor bioactivity. Some cells were harvested and processed For personal use only. on November 11, 2017. by guest www.bloodjournal.org From
Cultures.
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to obtain RNA for Northern analysis. Uninfected control marrow fibroblasts were generated in the same way, except that they were never exposed to virus or G418. For feeders producing both CSFs dishes of GM-CSF and G-CSF producing fibroblasts were trypsinized, mixed l:l, and replated at the same cell density. LTC experiments with CSF-producing feeders were initiated by seeding 5 x lo6 light density normal human marrow cells in 8 mL of modified a medium containing 12.5% FCS; 12.5% horse serum, mol/L hydrocortisone, and mol/L 2-mercaptoethanol (LTC medium) onto preestablished, confluent (but unirradiated) feeders, as specified. For LTC where soluble growth factor was added to the cultures after their establishment (ie, > 3 weeks), 2.5 x lo7 unprocessed nucleated marrow cells were suspended in 8 mL LTC medium in a 60-mm tissue culture dish and placed at 37°C for the first 3 days. All LTC were maintained at 33°C with weekly half-medium changes and demi-depopulation of the nonadherent cells. Nonadherent cells from representative cultures were cytospun onto glass slides, stained with Wright-Giemsa stain, and examined morphologically.
When recombinant growth factors were added to LTC this was performed 7 days after the regular medium change. In this case, each LTC received a "mock medium change"15 in which all of the old medium and cells were removed and then returned to the culture with or without the addition of growth factor. When LTC were sacrificed, nonadherent cells were counted and plated in methylcellulose assay. Adherent layer cells were harvested using either collagenase or trypsin.14 To determine the cycling status of primitive adherent layer progenitors, these cells were washed twice in nucleoside-free medium and then incubated with or without high specific activity "-thymidine as de~cribed.'~ Erythroid and GM colonies achieving different sizes were scored separately using established criteria that allow quiescent and cycling subpopulations to be distingui~hed.'~~'~
RESULTS
Generation of human CSF-producing feeders. Titers of recombinant retrovirus were measured as the number of G418 resistant ((3418') colonies of NIH-3T3 cells generated by 1 mL of growth medium obtained from the viral producer cells. Titers were greater than lo6 cfu/mL for PA317 cells producing either the GM-CSF or G-CSF viruses (Table 1) . Growth factor bioactivity generated by the highest titer producer cells was 10 ng/mL for the GM-CSF virus and 100 ng/mL for the G-CSF virus. N2 viral producers showed comparable viral titers, but no growth factor bioactivity. Confluent primary human marrow fibroblasts (obtained by subculturing normal LTC adherent layers) that were infected with the G-CSF virus released 20 ng/" G-CSF into the growth medium but no detectable Primary marrow infected with retrovirus and selected in G418 (see Materials and Methods). When these cells had formed confluent feeder layers the G418 selection was removed and their growth medium tested for GM-CSF or G-CSF bioactivity. These bioactivity levels remained stable for at least 8 weeks when such cells were maintained in LTC medium without G418.
GM-CSF activity. Conversely, similarly isolated cells infected with the GM-CSF virus produced 4 ng/mL GM-CSF bioactivity but no G-CSF (Table 2 ). This level of growth factor production remained stable for in excess of 8 weeks in culture without G418 selection. Unstimulated cells infected with the parent N2 virus never showed any evidence of production of either growth factor. Figure 2 is a Northern blot of total cellular RNA from either uninfected or GM-CSF producing feeders, after hybridization with a GM-CSF cDNA probe. Uninfected cells showed no GM-CSF RNA while infected cells showed the three expected RNA species. The two larger and more abundant forms are the full-length and spliced transcripts initiated from the retroviral LTR while the smaller, fainter band is initiated from the tk promoter attached to the GM-CSF cDNA. The far right lane shows the expected 1.2-kb GM-CSF transcript seen in PHA-stimulated lymphocyte RNA. Similar evidence of correctly initiated G-CSF transcripts was obtained when RNA from the G-CSFinfected cells was hybridized with a G-CSF cDNA probe (data not shown).
GM-CSF or G-CSF virus-infected human marrow fibroblasts were then used as adherent feeder layers in LTC seeded with normal, light density primary marrow cells as a source of primitive hematopoietic cells.'z Cultures with uninfected or N2-infected fibroblast feeders served as controls. There was no difference between the cultures with NZinfected and uninfected feeders according to any of the parameters measured. Figure 3 shows the number of nonadherent cells (ie, continuously produced mature granulocytes and macrophages) maintained in LTC with CSF-producing feeder cells as compared with controls. The total number of nonadherent cells approximately doubled when either GM-CSF-or G-CSF-producing feeders were present. This difference became readily apparent by week 3 of culture and persisted to at least week 5. There was no apparent change in the morphologic types of cells in the nonadherent fraction of any of the cultures. Figure 4 shows the effect of CSF-producing feeders on the total progenitor content in the same LTC. The majority ( > 60% by 5 weeks) of all progenitors were in the adherent layer and effects of the feeders were the same on both nonadherent and adherent progenitor numbers. Thus, the
LTC with human CSF-producing feeders.
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From data for both cell fractions have been combined for the comparisons shown. There was no change in either erythroid burst forming unit (BFU-E) or GM progenitor (CFU-GM) numbers in the LTC with CSF-producing feeders at 3 weeks. However, at 5 weeks there was a trend toward a decrease in both CFU-GM and BFU-E in the GM-CSF cultures. In contrast, a significant increase in the number of both of these progenitor types in the G-CSF cultures was seen. Neither the size nor the morphology of the colonies subsequently formed in the methylcellulose assays was demonstrably affected by the type of LTC from which the progenitors had been generated.
HOGGE ET AL
'H-thymidine suicide assays were performed to determine whether the presence of CSF-producing feeders could alter the regulation of proliferation of primitive progenitors located in the adherent layer of these LTC (Table 3) . Cells were harvested at the time of the regular weekly halfmedium change. At this time primitive BFU-E and CFU-GM in the adherent layer of standard LTC are q~iescent.'~.'~ This finding was confirmed in the present study where no significant progenitor kill was seen in either standard LTC (Table 4) , or LTC containing control (non-CSF-producing) feeders (Table 3) . Analysis of primitive BFU-E and CFU-GM from the GM-CSF cultures showed that the presence of these feeders had had no effect on the proliferative status of these cells. In contrast, in LTC with feeders producing G-CSF either alone or in combination with GM-CSF both types of primitive progenitors were in S-phase (Table 3) .
Addition of soluble growth factor to LTC (Table 4) . Because it had been previously shown14 that primitive adherent layer progenitors in established ( 2 3 weeks old) standard LTC initiated with unprocessed marrow without a preestablished feeder exhibit the same cycling characteristics as adherent layer progenitors in LTC with uninfected human marrow feeders regardless of whether the source of hematopoietic cells in the cocultures was T-cell-depleted peripheral blood mononuclear light density ( < 1.068 g/mL) marrow cells, or unprocessed marrow (data not shown), the experiments described in this section were performed using the former, simpler design without feeders. Thus, to determine whether the effects seen with the CSF-producing feeders could also be achieved by adding soluble growth factor to LTC, standard LTC werc initiated and maintained for 4 weeks. weekly half-medium change some cultures received a mock medium change with addition of various amounts of recombinant growth factor(s), and then after 2 or 3 days of further incubation, 'H-thymidine suicide assays were performed. Table 4 shows that the one-time addition of sufficient GM-CSF to achieve a concentration in the medium as high as 80 ng/mL did not induce the proliferation of primitive adherent layer progenitors. Identical results were obtained with G-CSF where concentrations of up to 150 ng/mL were tested. Bioactivity levels in the medium of these G-CSF cultures exceeded 35 ng/mL throughout the 2-to 3-day interval before assessing progenitor cycling status. Despite the fact that this level of G-CSF activity was higher than that achieved in the LTC containing G-CSF-producing feeders, progenitor cycling was not triggered in any of the five G-CSF addition experiments performed. G-CSF (150 ng/mL) was then added to LTC on 2 or 3 consecutive days. Primitive progenitor cycling was then assessed on the day after the last growth factor addition, at which time the G-CSF bioactivity level in the culture medium always exceeded 120 ng/mL. Only in the five experiments where the growth factor was added daily for 3 days were the primitive progenitors found to be in S-phase.
Growth Factor Dose Experiments EFU-Et CFU-GMS
In contrast to the results obtained with addition of even high doses of G-or GM-CSF alone, a single addition of as little as 5 ng/mL G-CSF in combination with 10 ng/mL GM-CSF consistently induced progenitor proliferation.
DISCUSSION
G-CSF and GM-CSF are likely candidates for regulation of hematopoiesis both in LTC and in the marrow microenvironment. A variety of cell types including fibroblasts, endothelial cells, macrophages, and T lymphocytes"'* are capable of producing these growth factors, and all of these cell types are found in LTC as well as in the marrow in
In the adherent layer of normal LTC, as in the vivo.l*," microenvironment of the bone marrow, most of the very primitive hematopoietic cells are q~iescent.'~ However, the ongoing production of functional, mature end cells in both
For personal use only. on November 11, 2017. by guest www.bloodjournal.org From systems requires that such cells must occasionally divide to allow the continuous production of differentiated progeny. In a complex, multicellular environment where many positive and negative regulators may be present at any one time it is difficult to determine whether or how a particular molecule contributes to an observed effect. In LTC, weekly half-medium changes involving the addition of fresh horse serum induce primitive progenitors in the adherent layer to enter S-phase. Northern analysis of RNA extracted from the adherent cells in these cultures has shown that the presence of horse serum in the fresh medium will also induce the production of both IL-1P and IL-6 mRNA.I6 Added IL-I@, in turn, will also induce progenitor cycling," as well as production of its own message and mRNA for 1L-6, G-CSF, and GM-CSF.I6 Because it has been difficult to show that JL-lp acts directly on human hematopoietic progenitors, it may be that the effects observed following its addition to LTC are due to the secondary release of these known regulators. However, it is also possible that unknown stimulatory factors are being induced or inhibitors downregdated. For example, transforming growth factor P (TGFp), a direct-acting negative regulator of primitive hematopoietic progenitors, will inhibit the cycling that is induced by IL-lp or other mesenchymal cell activators and appropriately timed addition of neutralizing antibodies to TGF-P will allow normally quiescent progenitors to remain continuously in ~y c l e . '~.~~ Thus, although cells of the marrow microenvironment can be induced to produce G-CSF and GM-CSF mRNA and increased levels of bioactive growth factor can be detected in LTC medium after stimulation with agents that induce progenitor cycling, it was not clear from previous studies what, if any, effect these latter factors would have on hematopoiesis in LTC.
In this study we have used feeders engineered to produce GM-CSF and G-CSF to selectively elevate the level of each of these factors in the LTC system and have evaluated the effects of these modifications at multiple levels of hematopoietic cell activity, ie, activation of very primitive progenitor cycling, amplification of the total clonogenic progenitor population, and the total final output of terminally differentiating granulopoietic cells. The results have clearly shown the ability of both of these growth factors to modulate hematopoietic activity in this complex system. They also demonstrate their distinct, albeit overlapping, activities. It appears that G-CSF can act on very primitive as well as later hematopoietic progenitors in the LTC system, whereas the action of GM-CSF as a single agent may be restricted to the terminally differentiating cells. In addition, the continuous provision of G-CSF by endogenous feeder production results in effects that are not seen with a single short exRosure to even very high doses of this factor. This result may explain why Coutinho et al" also found that rG-CSF, when added to human LTC (in weekly pulses to give concentrations of 50 to 100 ng/mL), was a relatively weak hematopoietic stimulus. It is also possible that the functional concentration of G-CSF seen by primitive hematopoietic cells in the adherent layer of cultures containing G-CSF producing feeders may be much higher (or more effective) than that suggested by levels of G-CSF in the medium. It has been shown that growth factors may be compartmentalized within the stromal layers by binding to glycoproteins or cell surface^.^^.^' The presentation of growth factors in a cellular context, perhaps in association with a cell surface molecule that has regulatory activity, could lead to effects not readily achieved with the soluble growth factor addition. While these are intriguing possibilities, experiments designed to look at the effects of continuous addition of growth factor throughout the culture period or to test the effect of feeders engineered to express a cell surface bound form of G-CSF will ultimately be required to ascertain the importance of microenvironmental presentation of growth factors.
Another interesting finding shown by the present study was the ability of GM-CSF and G-CSF to synergize with each other to stimulate the activation of very primitive clonogenic cells in LTC. Synergy of activity between many growth factors has been documented repeatedly in semisolid assays of hematopoietic colony-forming cells.4s5 Evidence of a similar synergy in the LTC system, given the complex mixture of cellular and molecular species present, provides considerable support for the view that these factors might have synergistic effects in vivo. Further analysis of the effects of additional growth factors in LTC (both alone and in combination) using the strategies outlined here may thus offer an important approach to predicting how to modulate hematopoiesis in vivo by growth factor therapy.
